The permeability barrier imposed by cellular membranes limits the access of exogenous compounds to the interior of cells. Researchers and patients alike would benefit from efficient methods for intracellular delivery of a wide range of membrane-impermeant molecules, including biochemically active small molecules, imaging agents, peptides, peptide nucleic acids, proteins, RNA, DNA, and nanoparticles. There has been a sustained effort to exploit cell penetrating peptides (CPPs) for the delivery of such useful cargoes in vitro and in vivo because of their biocompatibility, ease of synthesis, and controllable physical chemistry. Here, we discuss the many mechanisms by which CPPs can function, and describe a taxonomy of mechanisms that could be help organize future efforts in the field.
A Mechanistic Taxonomy of CPPs
In this Review, we define "cell penetrating peptides" (CPPs) as the ~1,000 known peptides with the ability to enter cells or deliver cargo. They function by a diverse and mutable assortment of membrane activities. A single CPP is not, by virtue of its sequence, structure or amphipathicity, necessarily internalized via a singular mechanism. Instead, we argue that a peptide is capable of gaining access to a cell's cytosolic compartment via multiple mechanisms and that varying a peptide's physical-chemical properties can influence the relative contribution of these various mechanisms to the uptake of a peptide. Here we present the idea of a landscape of internalization mechanisms. In any particular situation, internalization will depend on fixed factors that include peptide sequence and physical chemistry but also on variable factors such as local peptide concentration, local lipid composition, the response of the cell to the peptide, and much more. Furthermore, the entry mechanism(s) of any CPP will depend very strongly on the characteristics of the cargo, such that each peptide-cargo combination should be considered a unique molecule.
We illustrate a possible landscape of CPP mechanisms in Figure 1 (Key Figure) that is based on the idea that the most critical elements in describing the mechanism by which a CPP might translocate across membranes and deliver a cargo, under one specific set of conditions, are whether its internalization is mostly active (cell energy dependent) or passive (cell energy independent), and the degree to which it can disrupt membranes. The height of the landscape in Fig. 1 is indicative of the toxic membrane activity presumed to be undesirable in a CPP: significant, or long-lived disruption of the plasma membrane. On the other hand, potent membrane lytic activity is less toxic when combined with a strong dependence on uptake because disruption of the endosomal membrane is less toxic than disruption of the plasma membrane. Ultimately, the low "elevation" regions of the landscape are the areas that are potentially useful for cargo delivery by CPPs. In the context of Fig. 1 , we have defined five broad classes of activity, some of which might individually be best suited for the delivery of specific classes of cargo.
(1) Potent plasma membrane lysis
This is caused by peptides that permeabilize cell plasma membranes, and kill cells, at low concentration. CPPs are specifically selected not to have this property, although some acquire cytolytic activity at high concentration.
(2) Spontaneous membrane translocation
This occurs when a peptide passively translocates across membranes, at low concentration, without endocytosis or significant membrane disruption.
(3) Uptake (energy)-dependent membrane translocation
This occurs when an actively internalized (endocytosed) peptide is triggered by changing conditions in the endosome to translocate across endosomal membranes after uptake without significant membrane disruption. The changing conditions can include a decreasing luminal pH, a transmembrane pH gradient, proteolysis, disulfide reduction or a change in lipid composition.
toxic to cells, this mechanism can be useful for the delivery of actively uptaken cargo, including macromolecular cargo.
Much work has been done, mostly by trial and error, to modify sequences to improve internalization of CPPs, with some examples of success [1] [2] [3] [4] [5] [6] . Here we discuss the many overlapping mechanisms by which actively and passively internalized peptides, and attached cargo, interact with lipid bilayer membranes and bypass or disrupt membranes to gain access to the cell cytosol.
Many CPPs are Actively Internalized
We define a "cell penetrating peptide" as any peptide that can, to a measurable degree, enter the interior of living cells in cell culture, or deliver a membrane impermeant cargo. Energyindependent passive internalization occurs when peptide-cargo conjugate directly bypasses the cellular plasma membrane to enter the cytosol. This can occur via transient membrane disruption [7] or spontaneous translocation [8] as we discuss later. Energy dependent, active internalization occurs when a CPP triggers uptake via endocytosis. Relevant uptake mechanisms are numerous and their cell biology has been thoroughly reviewed elsewhere [9, 10] . Although specific biochemical mechanisms vary, in all cases, the cargo must be targeted to membrane-bound endosomes that are taken up into the cytosol.
Many pathogens take advantage of endocytic pathways to gain cellular access [11] , so it is not surprising that the original CPP sequence "tat", derived from the arginine-rich motif of the DNA-binding tat transcription factor of human immunodeficiency virus (HIV) [12] enters cells by endocytosis. Entry of tat is temperature-dependent, dynamin-1-independent, and is reduced by cytochalasin D and amiloride, drugs that block macropinocytosis, suggesting that this is the primary mechanism of entry [12] . However, clathrin-mediated and caveolar endocytosis are likely also involved [13] [14] [15] . Other well-studied CPPs, including penetratin and the simple tat analog Arg 9 , are also endocytosed [16] .
Electrostatic interactions between cationic peptides and anionic cell surface molecules such as glucosaminoglycans (GAGs) and other glycoconjugates are critical for the uptake of many CPPs, including tat [17] [18] [19] . Various CPPs are taken up with an efficiency that appears to be related to the binding stoichiometry between cell surface anions and peptide [17, 19] . At the same time, however, the mechanism of cell entry is sensitive to the cargo molecule [15] and can change with small changes in peptide sequence [16] . Some CPPs can enter cells by active and passive mechanisms simultaneously [16] .
The Diversity of Known CPPs
To access the cell interior, some CPPs may directly utilize active transporters [20] or cause endosomal lysis by the osmotic "proton sponge effect" [21] . However, most CPPs likely function by physically disrupting or bypassing either the plasma membrane, the endosomal membrane, or both; actions that are ultimately determined by the physical chemistry of peptide-membrane interactions. Here, we discuss the range of physical-chemical properties of the many known CPPs in order to better understand the diversity among CPP mechanisms.
We compiled a set of ~950 sequences that have been reported to enter cells and deliver polar cargo. About 90% of the sequences are from a CPP database [22] (http://crdd.osdd.net/ raghava/cppsite/) that was established in 2012. We supplemented the list with ~100 additional sequences found in the recent literature. After removing redundant sequences, the database contains 747 unique CPPs. Their efficiencies and mechanisms vary widely [22] . Unfortunately, most of these peptides deliver only dyes (63%) or biotin and other small molecules (33%) as proof of principle. Delivery of larger or useful cargos is very rare in the CPP literature; with proteins comprising only 4% of cargoes [22] . The exception is the delivery of oligonucleotides through complexation with CPPs, which is now routine in many cell types [23] . We will not review oligonucleotide delivery here. Approximately 45% of the CPP sequences are homologous or partially overlapping with other database entries as many researchers have studied variants of a few well-known CPPs; ~35% of the sequences are described in only one or a few papers, or studied by only one laboratory. The size and diversity of the database suggests that CPP behaviors are not highly dependent on specific primary sequences and that the functional sequence space for CPPs is probably enormous, at least with respect to entry of dye-labeled peptides into cells.
The distributions of the important physical properties of the known CPPs are shown in Fig.  2 , along with the values of some well-studied CPPs. Most CPPs are small, cationic peptides, with a median length of 14 residues and a median charge of +5 ( Fig. 2 A, B) . A median of 35% of CPP residues are cationic (Fig. 2C ), although this number ranges from 0 to 100%. Given the relatively tiny sequence diversity that is possible for the highly cationic peptides, they are extremely overrepresented. The overall interfacial hydrophobicity [24] of most of the known CPPs is not favorable for spontaneous partitioning into zwitterionic membranes (Fig. 2D) , distinguishing CPPs from other types of membrane active peptides, which are more hydrophobic [25] . For most CPPs, membrane binding requires electrostatic interactions or peptide amphipathicity, which promotes membrane binding by coupling it to structure formation [26] . Indeed, although most CPPs are not highly amphipathic, a subset of CPPs are, either when folded into an α-helix (Fig. 2E, see penetratin) , or when folded into a β-sheet structure (Fig. 2F) .
The sequence space for CPPs that can deliver a conjugated dye molecule "cargo" to cells is very large, therefore the discovery of novel CPPs or new variants of known CPPs may be a relatively trivial task, even by trial and error. In the end, as we discuss later, it will probably be more useful to focus future efforts on the discovery and engineering of peptides that exploit particular mechanisms, with the goal of enabling the efficient delivery of particular cargoes of genuine utility.
Archetypal Cell Penetrating Peptides
A small number of CPPs have been especially well studied or have mechanisms that represent the diversity of CPP mechanism discussed here. We introduce them next and review some of their characteristics.
Tat
The tat sequence is a naturally occurring CPP derived from the tat transcription factor of HIV. Mutational analysis of the full length HIV-tat protein revealed a short, highly basic, and unstructured N-terminal sequence (GRKKRRQRRR) that was necessary and sufficient for cell entry [27] and cargo delivery [28] . The mechanism of cellular entry for tat initially was thought to be energy-independent [28] , however, a general consensus has emerged that endocytosis is the primary mechanism of entry [17, 29] .
Oligoarginine
In an effort to understand and simplify the CPP motif of tat, researchers assessed the ability of synthetic oligoarginines to translocate into cells. Oligomers with between 6 and 12 arginines, the most common amino acid in CPPs [22] , entered cells, and nona-arginine (Arg 9 ) was found to be the optimal length [30] . Entry of Arg 9 into live cells is not dependent on chirality [31] but it is dependent on the backbone spacing between arginine residues [32] . Other homo-polycationic peptides of similar length (e.g., Lys 9 ) do not show the same ability to enter cells [30] . Arg 9 enters cells by endocytosis at low concentration (≤ 5 µM) [33] , but can cross the plasma membrane directly at high concentration (≥ 10 µM) [30, 34] .
Penetratin
Like tat, penetratin was discovered in a mutational analysis of a naturally occurring transactivating protein [35] . The antennapedia homeoprotein (pAntp) of Drosophilia contains a helical portion that, when mutated, causes the homeoprotein to not be internalized in vitro. The 16 residue third helix of pAntp (RQIKIWFQNRRMKWKK) proved to be the minimal motif for internalization, and was named penetratin [36] . Like many CPPs, the mechanisms of entry for penetratin are variable and depend on experimental conditions, especially peptide concentration [37] . Penetratin has been shown to enter cells via direct translocation and also by endocytosis [37, 38] . Penetratin internalization was shown to be dependent on the presence of glycosaminoglycans (GAGs) and on membrane domains created by either cholesterol depletion or ceramide formation in cell membranes [39] .
Transportan
The N terminus of galanin (a porcine neuropeptide) and mastoparan (a pore forming peptide found in wasp venom) were combined to form a chimeric CPP known as transportan (GWTLNSAGYLLGKINLKALAALAKKIL) [40] . Transportan, less cationic and more amphipathic than most CPPs, has faster kinetics of cell entry than tat and penetratin 25 . Transportan may have multiple mechanisms of entry at low concentration, including both energy-dependent and energy-independent internalization [41] . Interestingly, transportan was shown to enter various plant tissues in a non-endocytic manner [42] . A shortened variant, called transportan 10, or TP10, (AGYLLGKINLKALAALAKKIL) has even better activity [43] .
TP2
This peptide (PLIYLRLLRGQF), which is unrelated to TP10, was selected from a peptide library screened for soluble peptides that could spontaneously translocate across synthetic vesicle bilayers without membrane permeabilization [8] . TP2 conjugated to otherwise impermeant dye cargoes also showed rapid entry into eukaryotic cells at low concentration (<2 µM) and at room temperature, when endocytosis is inhibited [33] . As discussed later, it was proposed that monomeric TP2 enters cells via spontaneous membrane translocation [8, 33] .
These five archetypal peptides represent most of the known structural and mechanistic diversity of the cell penetrating peptides. In the sections that follow, we will refer frequently to these example peptides.
CPPs are Interfacially Active Peptides
CPPs have been studied in many synthetic bilayer systems with a wide collection of biophysical techniques. By virtue of their strong electrostatic interaction with anionic membrane surfaces and their sometimes amphipathic nature, many CPPs have "interfacial activity" defined as the ability to bind at the bilayer-water interface and perturb membrane structure( Fig. 3 ) [44] . Although the details vary widely, once the local concentration of an interfacially-active peptide rises above a threshold that is unique to each peptide, it can cooperatively disrupt the vertical segregation of hydrophobic and hydrophilic groups in a bilayer and allow the passage of polar molecules, minimally the peptide itself, across the membrane.
Experimentally, both electrostatic and hydrophobic contacts between peptide and lipids are important for CPP-membrane interaction [45, 46] . As predicted by their positive charge and unfavorable interfacial hydrophobicity (Fig. 2C ), CPPs typically have weak interaction with zwitterionic synthetic membranes and strong interaction with anionic membranes [47, 48] . Vesicle leakage, translocation and other experiments show that the inclusion of anionic lipids almost uniformly enhances CPP activity [49] [50] [51] [52] . When cationic CPPs are bound to anionic bilayers, especially when the peptide-to-lipid ratio is high (P:L ≥ 1:50), many effects are observed. Bilayer curvature can change [53] [54] [55] , membrane domain architecture can be affected [47, 54] , non-bilayer phases can form [56] , domains of clustered lipids and peptides can form [54, 57] , bilayer disorder can increase [53] or decrease [58] , vesicles can undergo aggregation and fusion [59] , lipid flip-flop can occur [56] , and entrapped contents can be released [49] [50] [51] . Which of these effects occurs, if any, is dependent on the CPP sequence, the peptide to lipid ratio, the lipid composition and many other experimental details.
Unlike tat and polyarginine, amphipathic CPPs fold into organized secondary structures in bilayers. For example, penetratin has mostly random coil secondary structure in buffer, whereas it adopts a helical structure in the presence of anionic lipids, to which it binds strongly [58, 60] . When at high concentration in bilayers, penetratin undergoes an additional transformation into an aggregated β -sheet structure [61] , highlighting the structural and functional plasticity of CPPs. Synthetic membranes are disrupted when penetratin binds and aggregates. This can involve the formation of lipid domains, an increase of bilayer thickness and curvature, and even tubulation of lipid vesicles at high P:L ratios [57] . Similarly, circular dichroism spectra and simulations showed that transportan 10 is highly helical when bound to vesicles, and inserts its hydrophobic face into the bilayer [43, 59, [62] [63] [64] . After insertion into synthetic lipid vesicles, transportan interacts with lipid phosphates causing lipid rearrangement and changes in local curvature in the bilayer [25, 47] . This plays a critical role in determining the peptide orientation and insertion depth into the interfacial region of the membrane [63] . Under some conditions transportan 10 can translocate across and permeabilize synthetic bilayers that do not contain anionic lipids [34, 65] .
The peptide TP2, discussed in detail later, appears to behave uniquely. It readily translocates across synthetic bilayers. Yet, in a neutron diffraction study of bilayer structure, TP2 was shown to have little or no effect on bilayer structure, even at very high local concentration, suggesting that it is possible for a peptide to translocate without significant membrane disruption [66] .
The image that emerges from the concept of CPPs as interfacially active peptides is not a static one. A peptide sequence and structure are not enough to define its mechanism of action under all conditions. Mechanism is also dependent on bound peptide concentration, lipid composition and other bilayer physical properties, temperature, ionic strength and many other factors. This leads us to the concept that each CPP occupies an area or areas in a continuum of mechanisms, as illustrated in Fig. 3 . As is the case for interfacially active peptides in general, there is little consensus on the detailed molecular mechanisms of CPPs in synthetic membranes [44, 67] . With only a few exceptions, our current knowledge provides little predictive power on the molecular mechanism or activity of specific CPPs on synthetic membranes. Furthermore, for some classes of CPPs, the mechanisms driving peptidemembrane interactions and translocation in synthetic bilayers may be different from the mechanisms that operate in the dynamic and heterogeneous environment of the cell membrane. As a result, vesicle experiments could have utility in predicting CPP function in cells only for some classes of CPPs, perhaps helping to explain why the CPP field discovers new peptides fortuitously, or by trial and error. Encouragingly, there are recent exceptions including in silico design [68] and targeted screening [8, 69, 70] , which suggest rational, targeted design is possible.
Translocation Across Membranes
Translocation, defined as the movement of a molecule across a bilayer, has been studied for many CPPs using a variety of techniques [8, 51, 65, 71, 72] . Yet, there is no consensus about which CPPs can translocate across synthetic bilayers and which, if any, do so without simultaneous membrane disruption. Highly cationic CPPs, above a variable threshold concentration, have been reported to effectively cross synthetic anionic bilayers [52, 56] . In many cases, this is likely due to disruption of the bilayer structure [7] . At low or moderate peptide concentrations, or in bilayers with low anionic lipid content, CPPs such as Arg9, tat, and penetratin neither translocate nor disrupt membranes [8, 52, 56, 72] . A novel fluorescence approach [71] to measure CPP translocation across synthetic bilayers was recently applied to Arg 9 tat, TP2 and other CPPs. All were found to rapidly cross anionic large unilamellar vesicles without permanent disruption of bilayer structure [52, 56, 71] , although transient disruption was not assessed. For tat, Arg9 and other highly cationic CPPs, the extent of translocation increases sharply with increasing peptide concentration, suggesting that the translocating species is a peptide multimer [52] . Furthermore, translocation is associated with transbilayer exchange (i.e. flip-flop) of anionic lipids, which can be triggered by small disruptions of bilayer structure, such as lipid density fluctuations, or large disruptions, such as pore-formation or reverse micelle formation [56] . Finally, translocation of these highly cationic CPPs is completely dependent on anionic lipids such as phosphatidylglycerol(PG) and decreased to near zero at approximately 50% anionic lipids in a phosphatidylcholine (PC) bilayer.
In contrast, transportan 10 does not require anionic lipids for translocation. This is probably because transportan 10 is more amphipathic and more hydrophobic than for example, tat, Arg9 and penetratin (Fig. 2) , and has less charge (+5 for transportan 10 compared to +8 to +10 for tat, Arg 9 and penetratin). In a study using a unique confocal microscopy approach, transportan 10 was shown to readily translocate into giant unilamellar vesicles (GUVs) made from PC without anionic lipids [65] , accompanied by a measurable influx of a charged dye molecule from solution [65] . The fact that there were no changes in the overall architecture of the GUVs suggests that transportan 10 only moderately disrupts membranes under these conditions. Interestingly, translocation and permeabilization occur on the same timescales, but are not temporally coupled. Translocation and permeabilization are not the result of a single process, although they must both be driven by related membrane activities. These studies show the power of simultaneous measurement of translocation and permeabilization (See Box 1).
As an aside, we note that peptide translocation into "giant" vesicles (diameter ≥ 10 µm) is 10 -100 fold faster than translocation into standard "large" unilamellar vesicles of diameter ~ 0.1 µm (Wimley, WC and Fuselier, T, unpublished). Thus, direct comparisons of the two systems should be made with caution.
Recent experiments with plasma membrane-derived vesicles are beginning to bridge the critical gap between synthetic bilayers and living cells. Such vesicles are made from native plasma membranes, and contain native lipids, membrane proteins and glycoconjugates, but lack energy-dependent cellular processes, including uptake machinery, obviating the need for problematic chemical or physical inhibition of endocytic mechanisms. Using such vesicles, it has been shown that there is a direct correlation between the cellular uptake of penetratin (and some analogs) and its binding to plasma membrane derived vesicles. Other experiments have shown that multiple CPPs, including tat, penetratin, transportan and transportan 10 can accumulate inside plasma membrane derived vesicles [73, 74] , although the degree of membrane disruption is unknown. Vesicle surface interactions are dynamic and driven by multiple cell surface moieties [75] . The translocation of CPPs across such native membranes favors liquid disordered membrane domains low in cholesterol and sphingomyelin [73, 74] .
Translocation without membrane disruption
There are a few peptides that, like most small molecule drugs, partition weakly into membranes and translocate "silently" across the bilayer without peptide clustering or significant membrane disruption [8] . This mechanism represents a unique subclass of CPPs that we have termed spontaneous membrane translocating peptides (SMTPs) [8, 33, 52, 56] .
SMTPs have different advantages, and disadvantages, compared to actively internalized or membrane-disrupting CPPs. Outside of the CPP field, the direct membrane translocation capabilities of cationic peptides were considered in the context of understanding the structure and function of the voltage sensor helices of voltage-gated potassium channels. These peptides move freely across bilayers when exposed to lipids as part of an intact channel protein [76] , and also translocate across synthetic bilayers as isolated peptides [72] despite the presence of four arginine residues. TP2 and related family members translocate across unilamellar and multilamellar synthetic lipid bilayers [8] , without membrane disruption, even in the absence of anionic lipids [33] . Apparently, TP2 does not require aggregation or self-assembly to translocate across bilayers; it binds only weakly to membranes, causes little or no permeabilization or disruption of membrane structure [66] , and readily translocates at very low concentration(P:L ≤ 1:1000) [8, 33] . Weak membrane binding is probably a requirement for such simple passive translocation, as strong binding would drive accumulation of peptide on the bilayer, likely leading to membrane disruption.
The TP2 family of peptides were discovered in a high throughput screen [8] that simultaneously selected for i) solubility, ii) rapid translocation of peptide across synthetic phosphatidylcholine bilayers containing 10% anionic lipids at low peptide concentration, and iii) a complete lack of membrane permeabilization in the same vesicles. The distribution of properties of the 10,368-member library screened to find TP2 very closely resembled the distribution of properties of known CPPs shown in Fig. 2 , including having members that are highly or completely cationic. In fact, the library contains the exact sequences of tat, Arg9 and several other known CPPs, but no sequences resembling any known CPP were identified as positives in the screen [8] . Instead, a unique family of peptides was identified. Intriguingly, the TP2 family peptides contain the same hydrophobe(ϕ)-arginine motif, ϕRϕϕR, found concatenated three times in the voltage sensor helix [72] . TP2 and related family members translocate across cellular membranes under conditions where endocytosis does not occur [33] . Thus, for SMTPs, testing of rational design and engineering ideas in synthetic bilayers may be relevant to the peptide activity in cellular membranes.
Arginine was preferentially selected over lysine in the screen for TP2 [8] , and is abundant in CPPs, overall, Fig. 2D [22] . The surprisingly low energetic cost for arginine partitioning into membranes [77, 78] is probably due to its especially favorable interactions with lipid phosphates [77] . This interaction has been proposed to be important in the spontaneous membrane translocation of arginine-containing hydrophobic sequences, like the voltage sensor domain, TP2-family sequences, and some other CPPs. Movement of SMTPs across membranes may be aided by bidentate interactions of the positively charged guanidinium group with the negatively charged phospholipid phosphate [79] [80] [81] , allowing for chaperoned diffusion [8, 33] of neutralized peptide-lipid complexes across the bilayer. It was recently shown that fatty acids in combination with a transmembrane pH gradient can also chaperone arginine-rich peptides across bilayers [82] , further supporting the idea that anionic amphiphiles such as lipid phosphates can do the same.
A Model of CPP Activity in Cells
Based on the interfacial activity of CPPs observed in synthetic bilayers, and on many cell studies, it is possible to relate the taxonomy of mechanisms in Figs. 1&3 with mechanistic scenarios for CPP activities in cell membranes, illustrated in Fig. 4 . Classical, highly cationic CPPs probably interact with cell surface glycoconjugates, anionic lipids, embedded membrane proteins, and sometimes the plasma membrane interfacial zone (Fig. 5D) . Above a threshold concentration for energy-dependent internalization that is likely unique for each peptide-cargo complex, polyvalent cell surface binding can trigger clustering of CPPs, possibly by a membrane damage response mechanism [83] , and subsequent uptake by endocytosis [13, 17, 37] . In Figs. 5A&C, example confocal microscopy images of cells incubated with dye labeled Arg 9 show that it is efficiently endocytosed. Once concentrated and internalized, CPPs may translocate across endosomal membranes or may reach the local membrane-bound concentration necessary for endosomal membrane disruption, resulting in at least partial peptide and cargo release into the cytosol. Endosomal membrane translocation or disruption may be triggered or aided by the dramatic changes in lipid composition and endosomal membrane stability that occur during endosome maturation [84, 85] , or by other endosome-specific environmental factors such as the acidic luminal pH and the transmembrane pH gradient [46] .
As shown in the illustration of Fig. 4 and the experimental images in Fig. 5A&D , it is also possible for CPP and cargo to remain trapped in endosomes and never be delivered to the cytosol. This is exacerbated by the fact that L-amino acid CPPs, which are the most commonly studied by far, are subject to proteolytic degradation after uptake [86] [87] [88] . Peptide degradation can begin shortly after uptake and can be mostly complete in ~1 -2 hours [86] [87] [88] . If the conditions required for endosomal translocation or disruption are not reached during that window, the peptide and possibly the cargo will be degraded or recycled without ever reaching the cytosol.
Above a threshold concentration that is distinct from, and usually higher than, the activeinternalization threshold, some CPPs may be able to reach a sufficiently high local concentration on the plasma membrane to form peptide-rich domains [14, 89] that can transiently disrupt the membrane [7] or promote peptide translocation and delivery of peptide and cargo into the cell cytosol. This is called Transient Plasma Membrane Permeabilization in Fig. 1 . For example, in a recent paper Arg9 labeled with the dye tetramethylrhodamine (TAMRA) was shown to efficiently enter cells directly through the plasma membrane at concentrations above 10 µM, but not at 5 µM or below [34] . Intriguingly, in at least this case, transient plasma membrane permeabilization was reportedly inhibited by depletion of cellular ATP and by depletion of intracellular calcium [34] , suggesting that the cell, through an unknown mechanism, could be an active participant in transient plasma membrane permeabilization.
The threshold local concentrations for CPP uptake or translocation across the plasma membrane are presumably highly variable, and depend on the peptide sequence, cargo, cell type and other factors. Both processes can occur simultaneously. These concentrations are also very difficult to measure or control (see Box 1) . Currently one of the most significant roadblocks to CPP utility is that many CPPs only efficiently deliver cargo to cells at relatively high concentrations (≥10 µM peptide), which saturates cell surfaces with peptide [14, 34, 89, 90] and can effect cell physiology [34, 83] . At those conditions, multiple mechanisms may be at play simultaneously. In one recent study, a cyclic tat peptide was able to deliver green fluorescent protein to the cell cytosol in vitro91]. Every example of macromolecular delivery is an important advance in the field, however in this case, concentrations of 50 -150 µM peptide-protein conjugate were needed to achieve delivery [91] . Such high threshold concentrations may be achievable in the laboratory, but they are somewhat impractical. Further, they prohibit clinical utility, a critical long-term goal of the field.
Unlike these well-known CPPs that cross the plasma membrane at high concentration due to transient plasma membrane permeabilization, spontaneous membrane translocating peptides can cross cell membranes at low concentration, presumably in a way that causes little or no disruption of cell physiology. For example, TP2 and related peptides readily enter the cell cytosol at 1-2 µM peptide (Fig. 5A&D ) [33] , which is useful, although such peptides are unlikely to be capable of delivering macromolecules.
Whether by transient plasma membrane disruption or by spontaneous membrane translocation, direct delivery across the plasma membrane bypasses the degradative environment of endosomal pathways. This is a critical factor for some cargo types. For example, the cytosolic delivery of bioactive peptides is becoming an especially important problem to solve in the rapidly developing field of inhibitors of protein-protein interactions in cells, which some authors have suggested will be the next great transformation in drug development [92, 93] . Effective small molecule inhibitors of protein-protein interactions have proven difficult to identify, whereas peptides that block protein-protein interactions can often be readily identified using available sequence and structure information [93] . Yet, bioactive peptides, once identified, are frequently too polar to efficiently access the cell cytosol and they are very sensitive to endosomal degradation [86] . Thus, an obvious route for delivery of bioactive peptides is directly through the plasma membrane, a mechanism that some CPPs are known to follow.
Mechanism Matters: Closing Thoughts
The CPP field has advanced significantly since the discovery of tat and penetratin peptides in the early 1990s. For example, one of the first investigational human drugs built around a CPP-like sequence (RT001, a topically applied Botulinum toxin) has performed well in human clinical trials [94] . Yet, in some ways, the field is still in a developmental stage, with much effort being made toward the discovery of novel CPPs that can deliver dye molecules, and much effort being made toward the ex post facto characterization of their mechanism (See Outstanding Questions). Still, our current mechanistic knowledge is almost purely observational, with little useful predictive power. Perhaps more importantly, the literature contains a surprising abundance of papers that come to different conclusions on the mechanism of action of the same CPPs. This may be due, in part, to the phenomenon described here in which a CPP can function across a continuum of mechanisms that is sensitive to a variety of experimental details. The mechanism of a CPP is not only an inherent characteristic of its sequence. This leads to problems in the commonly used peptide-centered approach to new CPP discovery. In that approach, dye-labeled peptides are first tested or screened for effective cell entry, followed by mechanistic studies to determine the route(s) by which the peptide enters cells or crosses bilayers. Finally, sometimes, the types of cargoes that can be delivered to cells by the peptide are determined.
The future of the CPP field is translational. Unquestionably, it will require a transition to a cargo-centered approach that begins with the identification of a cargo of genuine utility. Then CPPs with mechanisms appropriate for the delivery of that cargo will be iteratively tested, designed or engineered to deliver it. Finally, mechanistic studies will be done on successes and failures, to provide feedback for future CPP selection and design. Although our fundamental knowledge of the sequence-function relationships in CPPs is not yet sufficient for routine application of this approach, it may be sufficient to enable synthetic molecular evolution (i.e. rational, iterative library design and targeted screening [95] ) of CPPs to identify those that can deliver particular cargoes to cells in the laboratory. Ultimately, the far future of the field lies in the delivery of therapeutically useful cargoes targeted specifically to the appropriate cells and tissues in human patients.
Glossary

Cell penetrating peptide (CPP)
An exogenous peptide or peptide-cargo complex that can be detectably internalized into cells by any mechanism.
Uptake Also referred to as 'entry' and 'internalization.' The process of entering a cell from the outside. From the perspective of cellular energy, uptake can be active (energy-dependent) or passive (energy independent).
Endocytosis
Any active transport mechanism by which a cell engulfs material in a plasma membrane-derived, membrane-bound organelle. Major classes of endocytosis include clathrin-and caveolin-dependent endocytosis, as well as macropinocytosis and phagocytosis.
Translocation
The process of crossing a membrane from one side to the other, independent of mechanism.
Membrane disruption
Any process wherein the normally strict permeability barrier imposed by the lipid bilayer against polar molecules is diminished or circumvented. Disruption can be transient or long-lived, and the degree of permeabilization can range from minor (selective or shortlived) to catastrophic (non-selective or long-lived).
Transient plasma membrane disruption
The process by which a CPP transiently disrupts the cellular plasma membrane upon binding and accumulation on cell surfaces. Transient disruption may enable peptide or cargo internalization, but is not necessarily acutely cytotoxic.
Spontaneous membrane translocation
The process by which a CPP translocates across membranes as monomers or small multimers. As we define it, spontaneous translocation occurs by a mechanism that neither causes, nor requires membrane disruption.
Actively internalized peptide
A peptide or peptide-cargo conjugate that is uptaken into cells by endocytosis.
Cytolytic peptide
A peptide or peptide-cargo conjugate that causes significant or longlived disruption of the cellular plasma membrane, leading to significant cytotoxicity.
The Missing Links of CPP Experiments
Translocation or permeabilization?
Interfacially active peptides often cause transient disruption of membranes after which peptide-disrupted bilayers relax to non-perturbed states [44] . Measurement of synthetic membrane integrity after translocation does not necessarily provide information about whether or not membrane disruption occurred during translocation. It is critical to understanding CPP mechanism that both translocation and permeabilization of bilayers be measured at the same time, or over the same timescale and under the same conditions.
What is the local concentration?
There is a critical gap in knowledge of the interplay between cell surface binding, active or passive clustering, internalization, and degradation. The overall solution concentration of a peptide can be controlled, but the local concentration on a region of plasma or endosomal membrane is i) unknown and difficult to measure; ii) subject to rapid change due to simultaneous uptake, translocation, clustering and degradation; and iii) difficult to experimentally manipulate because it is not linearly related to solution concentration. Improved methods for measuring or controlling local concentrations of peptides on cell surfaces and in endosomes would be helpful to the field.
How much is too much?
In practice, it is possible to enable detectable cell entry of almost any cationic or amphipathic peptide by simply testing it at increasing concentrations until entry is observed. Concentrations of cationic peptides greater than a few µM are likely to saturate cell surfaces and could affect cell physiology and function, and would preclude most clinical applications. The CPP field would benefit from the use of better methods for quantitating the efficiency of cargo delivery as a function of CPP concentration. This would enable the field to focus on developing CPPs that efficiently deliver useful cargoes to cells at relatively low concentrations.
Do my eyes deceive me?
The CPP field relies heavily on laser scanning confocal fluorescence microscopy for assessing uptake. Although this technique is powerful and indispensable, it also has weaknesses. Specifically, imaging is often qualitative and susceptible to manipulation, automatic or manual intensity scaling (which can obscure actual concentrations), selfquenching of clustered and internalized dyes (which can mask concentrated pools of peptide), and pH and other effects (which can change dye intensity). For example, fluorescein, sometimes also called FITC, is widely used in CPP studies [22] despite the fact that its fluorescence is quenched at the pH of acidified endosomes. The convenience of fluorescent dyes as "cargo" has caused much of the field to focus, almost exclusively, on the discovery of peptides that can deliver dyes, instead of useful cargoes. The field will be better served by diversified approaches, such as some labs are pursuing [96] , for detecting and quantitating the delivery of useful cargoes to cells.
Trends Box
• The functional sequence space for cell penetrating peptides (CPPs) is vast. Recent data from computational, synthetic and biological systems show that the mechanisms by which they bypass membranes are similarly diverse.
• CPP mechanism is mutable; it is not determined by the peptide sequence only. Many other experimental and biological factors are important, including local peptide concentration, local lipid composition and the properties of the cargo.
• The position of a CPP within the mechanistic taxonomy, under one set of conditions, can be described by the degree to which it is taken up by endocytosis, and the degree to which it can disrupt membranes.
• Transformation from a peptide-centric approach to a mechanistic and cargocentric approach may enable the CPP field to fulfill its long held promise. • Is there a mechanistic class of CPP, such as endosome lytic peptides, that is most suitable for the delivery of proteins and other macromolecules to cells in culture? Can the routine delivery of macromolecules be achieved at low peptide concentration?
• How can we best assess the constraints on cargo that can be delivered by particular CPPs? Can we establish "gold standards" throughout the field of CPP research in order to uniformly assess the efficiency and mechanism of cell entry?
• How can we improve synthetic model systems to better mimic the complex environment of the cell?
• How can we improve computational approaches to predict the mechanism of CPP entry?
• How might we use knowledge gained from mechanistic studies of CPPs to overcome other biological barriers such as the blood brain barrier or the placental barrier?
• How can we rationally design CPPs to enter specific cell types and tissues for targeted therapies? Frequency distributions of various physical properties 747 non-redundant cell penetrating peptides. A: Total peptide length. B: Net charge assuming pH 7.4, C-terminal amidation, and no contribution from histidine. C: Wimley-White interfacial hydrophobicity score [26] for the CPP sequences, assuming an C-terminal amide and an N-terminal amino group. Positive is unfavorable for partitioning. D: Fraction of residues that are cationic, excluding histidine. E: Helical hydrophobic moment [97] . F: Absolute value of the β-sheet hydrophobic Schematic illustration of some of the overlapping mechanisms by which a peptide may cross a membrane. The effect of peptide on the membrane is also indicated. A: Spontaneous translocation of monomeric peptide that occurs without membrane disruption. B: Translocation that requires some peptide self-assembly, but not membrane disruption. C: Translocation that requires significant peptide aggregation and minor membrane disruption. D: Translocation that requires peptide self-assembly and moderate (i.e. selective or shortlived) membrane disruption. E: Translocation associated with peptide self-assembly into a structure that drives non-selective or long-lived membrane permeabilization. In this scenario, even large polar molecules pass through the membrane. This mechanism will be acutely toxic if it occurs in plasma membranes, but not if it is confined to endosomal membranes. These illustrations represent snapshots of states in a continuum of mechanisms. The arrows show some of the possible transitions between mechanisms that could arise from many experimental factors, including peptide sequence and physical; chemistry, local peptide concentration, and anionic lipid content. Schematic illustration of some of the various mechanisms by which a CPP and attached cargo may be internalized into a cell. The fate of an unattached small molecule and macromolecule are also shown. A: Spontaneous membrane translocation across the plasma membrane, which occurs without peptide self-assembly or membrane disruption (See Fig.  5B & E) . B: Transient plasma membrane permeabilization. C: Endocytosis of membrane bound peptide-cargo complex, along with unattached small and large molecule cargoes. D: Endosomal membrane lysis, or large scale disruption, releases the CPP-cargo conjugate and all co-encapsulated cargoes. E: Translocation across the endosomal membrane delivers CPP and attached cargo, but not co-encapsulated cargo. F: Degradation or recycling of CPP and all cargoes will occur rapidly if the other mechanisms do not enable delivery to the cytosol (See Fig. 5A&C ). The mechanisms depicted are not mutually exclusive; they can happen concurrently. Example confocal microscopy images of fates of dye-labeled CPPs in Chinese hamster ovary cells under various conditions. Here we show behaviors of a classical, highly cationic CPP, Arg 9 , and a spontaneous membrane translocating peptide (SMTP) TP2. Both. Both peptides, which were described earlier, are labeled with the red dye tetramethylrhodamine (TAMRA). In some images, the cell media contains Alexafluor488-labelled dextran (green) an aqueous phase probe that is passively entrapped in endosomes. A: Endosome entrapment. Cells incubated at 37°C for 2 hours with 2 µM Arg 9 -TAMRA show punctate red intensity that is always associated with endosomes. At concentrations less than 5 µM Arg 9 , delivery to the cytosol is insignificant, and the entrapment of the TAMRA cargo does not change even after 24 hours. B: Spontaneous membrane translocation. Cells incubated with 2 µM TP2-TAMRA at room temperature for as little as 10 minutes show diffuse cytosolic fluorescence, indicating plasma membrane translocation. C: Active uptake. Cells simultaneously incubated with 2µM Arg 9 -TAMRA and labeled dextran at 37°C show that dextran fluorescence often overlaps with TAMRA fluorescence in intracellular organelles. This observation demonstrates that Arg 9 , at low concentration, enters cells only through endocytosis. D: No uptake. Cells simultaneously incubated with 2µM Arg 9 -TAMRA and labeled dextran at room temperature, which inhibits endocytosis, show that neither Arg 9 nor dextran enter cells appreciably under these conditions. However, it is clear that Arg 9 binds strongly to the plasma membrane. Above 10 µM Arg 9 , on the other hand, delivery of TAMRA to the cytosol and nucleus by Arg 9 is significant [34] . E: Spontaneous membrane translocation. Incubation of cells with TP2-TAMRA and labeled dextran at room temperature show that TP2 is internalized into cells without simultaneous entry of dextran. This observation, and others [33] , indicate that endocytosis is not required for TP2 internalization.
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